269 related articles for article (PubMed ID: 8540540)
1. Mechanisms of pennicillamine and zinc in the treatment of Wilson's disease.
Farinati F; Cardin R; Mestriner C; Sturniolo GC; Naccarato R
Am J Gastroenterol; 1995 Dec; 90(12):2264-5. PubMed ID: 8540540
[No Abstract] [Full Text] [Related]
2. The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease.
Yarze JC
Am J Gastroenterol; 1995 Jun; 90(6):1026. PubMed ID: 7771405
[No Abstract] [Full Text] [Related]
3. [Treatment of Wilson's disease with zinc. 5 cases].
Bona I; Broussolle E; Neuschwander P; Confavreux C; Fontanges T; Accominotti M; Chazot G
Rev Neurol (Paris); 1993; 149(6-7):393-7. PubMed ID: 8303158
[TBL] [Abstract][Full Text] [Related]
4. Copper and zinc in the serum, urine, and hair of patients with Wilson's disease treated with penicillamine and zinc.
Dastych M; Procházková D; Pokorný A; Zdrazil L
Biol Trace Elem Res; 2010 Mar; 133(3):265-9. PubMed ID: 19562272
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of Wilson's disease].
Hoogenraad TU; van Hattum J
Dtsch Med Wochenschr; 1987 Jun; 112(23):942-3. PubMed ID: 3582206
[No Abstract] [Full Text] [Related]
6. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
[TBL] [Abstract][Full Text] [Related]
7. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Wilson's disease.
Brewer GJ; Yuzbasiyan-Gurkan V; Young AB
Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455
[No Abstract] [Full Text] [Related]
9. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
[TBL] [Abstract][Full Text] [Related]
10. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
Germinario L; Campanella G; D'Addabbo A
Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
[No Abstract] [Full Text] [Related]
11. Successful long term oral zinc in florid Wilson's disease: a case report.
Kaur U; Bambery P; Bhushnurmath SR; Deodhar SD; Dilawari JB
Trop Geogr Med; 1988 Apr; 40(2):161-5. PubMed ID: 3407008
[TBL] [Abstract][Full Text] [Related]
12. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
13. [Maintenance treatment of Wilson's disease with oral zinc. Apropos of a child treated for 4 years].
Alexiou D; Hatzis T; Koutselinis A
Arch Fr Pediatr; 1985; 42(6):447-9. PubMed ID: 4051676
[TBL] [Abstract][Full Text] [Related]
14. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
Hoogenraad TU
Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Wilson's disease with zinc. IX: Response of serum lipids.
Brewer GJ; Yuzbasiyan-Gurkan V; Johnson V
J Lab Clin Med; 1991 Nov; 118(5):466-70. PubMed ID: 1940587
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Wilson's disease with zinc. V. Changes in serum levels of lipase, amylase, and alkaline phosphatase in patients with Wilson's disease.
Yuzbasiyan-Gurkan V; Brewer GJ; Abrams GD; Main B; Giacherio D
J Lab Clin Med; 1989 Nov; 114(5):520-6. PubMed ID: 2478644
[TBL] [Abstract][Full Text] [Related]
17. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
Günther K; Siegemund R; Lössner J; Kühn HJ
Radiobiol Radiother (Berl); 1988; 29(2):226-9. PubMed ID: 3399664
[No Abstract] [Full Text] [Related]
18. [Therapeutic approaches to Wilson's disease].
Meiner Z
Harefuah; 1990 Mar; 118(5):296-8. PubMed ID: 2344986
[No Abstract] [Full Text] [Related]
19. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
20. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
